U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07773610) titled 'Study of Combinations of Novel Promising Drugs for Pulmonary Tuberculosis' on July 21.
Brief Summary: A phase 2, two-part, multicentre, open label, controlled, randomised clinical trial in adult participants with newly diagnosed, sputum-positive pulmonary drug-sensitive tuberculosis (DSTB). Assessing the Safety and Efficacy of TBAJ-587 as Part of a Combination Regimen in Newly Diagnosed, Drug-Sensitive, Sputum-Positive Pulmonary Tuberculosis
Study Start Date: July 23
Study Type: INTERVENTIONAL
Condition:
Tuberculosis, Pulmonary
Intervention:
DRUG: TBAJ-587 50 mg
TBAJ-587LD Tablet 50 mg 100 mg OD TBAJ-587HD Tablet 50 mg 200 mg...